UBS AM’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,209
| Closed | -$479K | – | 2628 |
|
|
2016
Q3 | $479K | Sell |
1,209
-378
| -24% | -$150K | ﹤0.01% | 2004 |
|
|
2016
Q2 | $550K | Sell |
1,587
-20,797
| -93% | -$7.21M | ﹤0.01% | 1915 |
|
|
2016
Q1 | $18.6M | Buy |
22,384
+209
| +0.9% | +$174K | 0.02% | 688 |
|
|
2015
Q4 | $23.2M | Buy |
22,175
+3,733
| +20% | +$3.91M | 0.03% | 616 |
|
|
2015
Q3 | $14.5M | Buy |
18,442
+6,261
| +51% | +$4.91M | 0.02% | 771 |
|
|
2015
Q2 | $16M | Buy |
12,181
+3,036
| +33% | +$3.99M | 0.02% | 781 |
|
|
2015
Q1 | $18.6M | Buy |
9,145
+1,072
| +13% | +$2.18M | 0.02% | 732 |
|
|
2014
Q4 | $15.5M | Buy |
+8,073
| New | +$15.5M | 0.01% | 760 |
|